Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...

The World Health Organization (WHO), has raised the alarm that Nigeria loses about $1.2billion yearly from its economy to ...

WHO endorses biannual injectable Lenacapavir for HIV prevention. This long-acting PrEP offers hope for high-risk groups and ...

In 2024, 89% of infants globally—about 115 million—received at least one dose of the diphtheria, tetanus, and pertussis (DTP) ...

Uganda strengthens border health amid ongoing threats Health | AGENCIES | Uganda’s borders have always been busy and ...

WHO: The agency has long called for expanded medical corridors, including the full resumption of the pre-war traditional referral pathway to hospitals in the West Bank and East Jerusalem.

TANZANIA is among countries expected to benefit from the upcoming rollout of injectable lenacapavir for HIV prevention, following a landmark recommendation by the World Health Organization (WHO).

The World Health Organization, alongside the International Telecommunication Union and the World Intellectual Property Organization, has released a technical report warning of risks associated with ...

The World Health Organization has called on more countries to treat patients from the Gaza Strip after the medical evacuation ...

Soft tissue cytopathology plays a vital role in the diagnosis and management of soft tissue neoplasms, necessitating a standardized classification ...

New research shows that medical professionals need greater awareness of the implications of social isolation on human health. Just as importantly, they need awareness of solutions.